institution 2,129 words
Contents

VA Parkinson's Disease Research Program

No AI portrait yet

Agent Input

💡 Improve this page

🌐 Cross-references

RORWikipedia

Related Hypotheses (39)

Closed-loop transcranial focused ultrasound with gamma entra
Score: 0.00
Closed-loop optogenetic targeting PV interneurons to restore
Score: 0.96
Closed-loop tACS targeting EC-II parvalbumin interneurons to
Score: 0.87
Closed-loop transcranial focused ultrasound to restore hippo
Score: 0.87
Optogenetic restoration of hippocampal gamma oscillations vi
Score: 0.87
Gamma Oscillation Entrainment Enhances lncRNA-9969-Mediated
Score: 0.87
Closed-loop focused ultrasound targeting EC-II PV interneuro
Score: 0.86
Closed-loop transcranial focused ultrasound to restore hippo
Score: 0.83
Closed-loop tACS targeting EC-II PV interneurons to suppress
Score: 0.81
Closed-loop transcranial focused ultrasound targeting CA1 PV
Score: 0.80
Prefrontal sensory gating circuit restoration via PV interne
Score: 0.78
Synaptic Vesicle Cycle Hijacking: Shared Convergent Mechanis
Score: 0.76
Closed-loop focused ultrasound targeting CA1 PV interneurons
Score: 0.75
Complement C1QA Inhibition Synergizes with PV Interneuron Mo
Score: 0.66
Parvalbumin Interneuron Vulnerability Links Lactate Transpor
Score: 0.66
Optogenetic PV Cell Activation Restores Gamma Power via PV P
Score: 0.64
Gamma entrainment therapy to restore motor cortical inhibito
Score: 0.63
APOE4-Targeted Ultrasonic Lipidation Enhancement for Gamma O
Score: 0.62
Optogenetic viral vector delivery via tFUS-mediated blood-br
Score: 0.62
Ketone-Based Metabolic Switching to Restore PV Interneuron F
Score: 0.61
pg 1/2Next →

Related Analyses (10)

TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed
GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed
Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed

Related Experiments (30)

TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.45
AAV-LRRK2 IND-Enabling Study Design
clinical · proposed · Score: 0.40
AAV Serotype Comparison for LRRK2 Knockdown in PD
validation · proposed · Score: 0.40
Alpha-Synuclein SAA Kinetics Study — Biological Staging Back
clinical · proposed · Score: 0.40
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40

Knowledge Graph (8 edges)

PYRUVATE_DEHYDROGENASE participates_in PROTEIN_COMPLEXES
DENERVATION regulates SKELETAL_MUSCLE
HSPA1A associated_with MICROVASCULAR_COMPLICATIONS
HSPA1B associated_with MICROVASCULAR_COMPLICATIONS
HLA-DRA associated_with MICROVASCULAR_COMPLICATIONS
AGER associated_with MICROVASCULAR_COMPLICATIONS
SOCIAL_DISADVANTAGE causes ACCELERATED_AGING
SOCIAL_DISADVANTAGE activates AGE_RELATED_DISEASES

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.